human | Q5 |
P6178 | Dimensions author ID | 01354603102.36 |
P10058 | IRIS UNIBO author ID | 38286 |
P10762 | IRIS UNIMORE author ID | 04479 |
P496 | ORCID iD | 0000-0002-3633-8818 |
P11725 | PubliCatt author ID | 22331 |
P1153 | Scopus author ID | 16439271400 |
P108 | employer | University of Bologna | Q131262 |
P734 | family name | Cortelli | Q115158395 |
Cortelli | Q115158395 | ||
Cortelli | Q115158395 | ||
P735 | given name | Pietro | Q15897583 |
Pietro | Q15897583 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q125589774 | A Brief History of Stereotactic Atlases: Their Evolution and Importance in Stereotactic Neurosurgery |
Q40426380 | A brief appraisal on some aspects of the receptor-receptor interaction |
Q48397649 | A case of fatal familial insomnia in Africa |
Q53166533 | A case of strictly unilateral migraine without aura transformed in an episodic hemicrania continua. |
Q56997367 | A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse |
Q44354243 | A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes |
Q50629867 | A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism. |
Q46328035 | A new integrated instrumental approach to autonomic nervous system assessment. |
Q84235530 | A new method to quantify catecholamine stores visualized by means of the Falck-Hillarp technique |
Q40654356 | A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene). |
Q56353437 | A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea |
Q36594397 | A proposal for a national registry on chronic migraines |
Q92263382 | A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study |
Q93083255 | A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years |
Q40240624 | A study on the effects of interaction between naloxone and 2-Br-alpha-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serum |
Q92163985 | A2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence |
Q48413495 | A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes |
Q54274138 | Abdominal neuropathy after renal surgery. |
Q72496639 | Abnormal platelet mitochondrial function in patients affected by migraine with and without aura |
Q34216671 | Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans |
Q61959315 | Abnormal sympathetic skin responses in thalamic lesions |
Q48682010 | Absence of sleep EEG markers in fatal familial insomnia healthy carriers: a spectral analysis study. |
Q37005403 | Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease |
Q47749150 | Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles |
Q48400873 | Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity |
Q37964074 | Agrypnia excitata |
Q47555639 | An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia |
Q37022111 | Analysis of LMNB1 duplications in autosomal dominant leukodystrophy provides insights into duplication mechanisms and allele-specific expression |
Q57814269 | Analysis ofLMNB1Duplications in Autosomal Dominant Leukodystrophy Provides Insights into Duplication Mechanisms and Allele-Specific Expression |
Q53239728 | Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache. |
Q33154956 | Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients |
Q48162929 | Association between restless legs syndrome and hypertension: a preliminary population-based study in South Tyrol, Italy |
Q48106023 | Association between restless legs syndrome and migraine: a population-based study. |
Q47202583 | Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. |
Q51092760 | Autonomic and hormonal ictal changes in gelastic seizures from hypothalamic hamartomas. |
Q72929542 | Autonomic function in migraine |
Q56987322 | Autonomic innervation in multiple system atrophy and pure autonomic failure |
Q59389266 | Autonomic nervous system function in myotonic dystrophy |
Q81603447 | Autonomic nervous system laboratories: a European survey |
Q56379583 | Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study |
Q37998735 | Baroreflex modulation during sleep and in obstructive sleep apnea syndrome |
Q38330340 | Bidirectional interactions between the baroreceptor reflex and arousal: an update |
Q30495484 | Bilateral paramedian thalamic syndrome: abnormal circadian wake-sleep and autonomic functions |
Q37273175 | Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial. |
Q41149122 | Blood pressure rhythms in sleep disorders and dysautonomia |
Q30981396 | Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy |
Q47902364 | Brain structural profile of multiple system atrophy patients with cognitive impairment |
Q38798203 | Brain-heart interactions: physiology and clinical implications. |
Q48742946 | CT scan in a case of progressive generalized dystonia with amyotrophic paraplegia. |
Q48847067 | Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome |
Q38543028 | Cardiovascular autonomic dysfunctions and sleep disorders |
Q51652008 | Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage. |
Q56989681 | Cardiovascular changes during maximal breath-holding in elite divers |
Q48909379 | Cardiovascular dysautonomia in fatal familial insomnia |
Q46519577 | Cardiovascular variability as a function of sleep-wake behaviour in narcolepsy with cataplexy |
Q44410147 | Cardiovascular-sleep interaction in drug-naïve patients with essential grade I hypertension |
Q33156302 | Central and cardiovascular responses to emotional stimuli are normal in non-phobic subjects with Reflex Syncope |
Q40345394 | Central and peripheral autonomic failure in cold-induced sweating syndrome type 1. |
Q36940443 | Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study |
Q80757653 | Cerebrospinal fluid and serum neuron-specific enolase in acute benign headache |
Q56985525 | Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache |
Q59718885 | Chapter 29 Sleep and autonomic nervous system dysfunction |
Q35522685 | Chronic migraine classification: current knowledge and future perspectives |
Q47993109 | Chronomedicine: a necessary concept to manage human diseases |
Q51564763 | Chronotypes in menstrual migraine: a case-control study. |
Q64780297 | Circadian rhythms of cardiovascular autonomic function: Physiology and clinical implications in neurodegenerative diseases |
Q38953697 | Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study |
Q62844764 | Clinical and genetic characteristics of late-onset Huntington's disease |
Q33492954 | Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. |
Q98729951 | Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series |
Q72526366 | Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study |
Q38260817 | Cognitive and sleep features of multiple system atrophy: review and prospective study |
Q37490550 | Cognitive function in peripheral autonomic disorders |
Q45296102 | Comment on 'Huntington's disease presenting as ALS'. |
Q38013723 | Comorbidity in perimenstrual migraine |
Q34393819 | Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study |
Q35606698 | Complex movement disorders at disease onset in childhood narcolepsy with cataplexy |
Q55952131 | Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome |
Q33159812 | Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. |
Q63248126 | Corrigendum to “Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles” [Physiol. Behav. 142 (2015) 79–84] |
Q97888391 | Covid-19-associated encephalopathy and cytokine-mediated neuroinflammation |
Q40087959 | Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders |
Q43577841 | Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. |
Q38287343 | Diagnosis and management of autonomic failure in neurodegenerative disorders |
Q28295298 | Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease |
Q44533741 | Direct stimulation of the autonomic nervous system modulates activity of the brain at rest and when engaged in a cognitive task. |
Q48819867 | Dissociated 24-Hour Patterns of Somatotropin and Prolactin in Fatal Familial Insomnia |
Q48834146 | Do autonomic cardiovascular reflexes predict the nocturnal rise in blood pressure in obstructive sleep apnea syndrome? |
Q47127236 | Do changes of ANS in migraine subjects play a pathogenetic role? |
Q48389151 | Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients? |
Q81021201 | Does headache represent a clinical marker in early diagnosis of cerebral venous thrombosis? A prospective multicentric study |
Q48642862 | Does the prion protein gene 129 codon polymorphism influence sleep? Evidence from a fatal familial insomnia kindred |
Q34919409 | Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis |
Q33154189 | EFNS guidelines on the diagnosis and management of orthostatic hypotension. |
Q39188639 | Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel gro |
Q45304674 | Eating disorder as a psychiatric onset of juvenile Huntington's disease |
Q56994576 | Effect of deep brain stimulation of the posterior hypothalamic area on the cardiovascular system in chronic cluster headache patients |
Q37024822 | Effect of parasympathetic stimulation on brain activity during appraisal of fearful expressions |
Q48102574 | Effect on sleep of posterior hypothalamus stimulation in cluster headache |
Q43415793 | Effects of sulpiride isomers on the control of anterior pituitary secretion in normal man. |
Q58877328 | Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks |
Q33671824 | Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura |
Q38108485 | Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies. |
Q102066176 | Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke |
Q44993787 | Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor |
Q34460780 | Endozepines in recurrent stupor |
Q56378935 | Energy Metabolism Impairment in Migraine |
Q56380713 | Epigenetic DNA methylation changes in episodic and chronic migraine |
Q98774363 | Erenumab efficacy in highly resistant chronic migraine: a real-life study |
Q98830488 | Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center |
Q46433690 | Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity |
Q35798205 | Evidence-based diagnosis of nontraumatic headache in the emergency department: a consensus statement on four clinical scenarios |
Q33153567 | Fainting in your sleep? |
Q28185765 | Familial and sporadic fatal insomnia |
Q48553901 | Familial hemiplegic migraine: clinical features and probable linkage to chromosome 1 in an Italian family |
Q46097260 | Family history for chronic headache and drug overuse as a risk factor for headache chronification |
Q43912582 | Fatal cerebral haemorrhage after liver transplantation in a patient with transthyretin variant (gly53glu) amyloidosis |
Q48174358 | Fatal familial insomnia: clinical features and molecular genetics |
Q40553060 | Fatal familial insomnia: sleep, neuroendocrine and vegetative alterations |
Q28294605 | Fatal insomnia and agrypnia excitata: sleep and the limbic system |
Q57243916 | Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease |
Q34664152 | Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial |
Q37870791 | Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies |
Q52541439 | Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy. |
Q43885552 | Gait disorders in fatal familial insomnia. |
Q34403982 | Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. |
Q38553453 | Genomics and epigenomics |
Q44698492 | Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. |
Q57812874 | Guía de práctica clínica para el diagnóstico y manejo del síncope (versión 2009) |
Q61853995 | Headache and anxiety–depressive disorder comorbidity: the HADAS study |
Q53281952 | Headache and hypertension. |
Q35967824 | Headache in epilepsy: prevalence and clinical features |
Q37188666 | Headache in the emergency department. How to handle the problem? |
Q36261216 | Headache, anxiety and depressive disorders: the HADAS study |
Q83318857 | Headache: clinical governance in health care management in the Emergency Department |
Q24337084 | Hereditary early-onset Parkinson's disease caused by mutations in PINK1 |
Q54418514 | High frequency of migraine-only patients negative for the 3243 A>G tRNALeu mtDNA mutation in two MELAS families. |
Q56355645 | Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes |
Q48581847 | Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism |
Q33696397 | Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation |
Q56378366 | Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache |
Q33378590 | Idiopathic central sleep apnoea syndrome treated with zolpidem |
Q56355674 | Illness perception in patients with migraine: An exploratory study in a tertiary care headache centre |
Q48456089 | Impaired cortical and autonomic arousal during sleep in multiple system atrophy |
Q48272070 | Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study |
Q37767249 | Increased prevalence of sleep disorders in chronic headache: a case-control study |
Q43172862 | Insomnia cycling with a 42-day infradian period: evidence for two uncoupled circadian oscillators? |
Q46361653 | Insulin resistance to both glucose and aminoacid metabolism in a patient with Fatal Familial Insomnia |
Q100497012 | Intravenous immunoglobulin therapy in COVID-19-related encephalopathy |
Q44520847 | Investigation of an LDLR gene polymorphism (19p13.2) in susceptibility to migraine without aura |
Q80727975 | Investigation of the T3111C CLOCK gene polymorphism in cluster headache |
Q42714191 | Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? |
Q33729387 | Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy. |
Q37750556 | Is migraine a disease? |
Q43309758 | Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex |
Q56992671 | Isolated generalised anhidrosis induced by postganglionic sympathetic skin nerve fibre degeneration: an incomplete Ross syndrome? |
Q56986863 | Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy |
Q56985999 | Italian Law "measures to guarantee the access to palliative and pain treatments": rebound on headaches' management |
Q56376530 | LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study |
Q36260898 | Lack of association between five serotonin metabolism-related genes and medication overuse headache |
Q57721327 | Lack of association between mitochondrial tRNALeu(UUR) point mutation and cluster headache |
Q34072629 | Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts |
Q33343043 | Lessons from 8 years' experience of hypothalamic stimulation in cluster headache. |
Q101459677 | Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia |
Q69989994 | Long-term prognosis after carotid endarterectomy |
Q54522196 | Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? |
Q37381065 | Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. |
Q57203469 | Magnetic resonance spectroscopy of episodic ataxia type 2 and migraine |
Q36726158 | Magnetic resonance spectroscopy studies in migraine. |
Q39868917 | Messenger RNA processing is altered in autosomal dominant leukodystrophy |
Q56984588 | Microneurographic evaluation of sympathetic activity in small fiber neuropathy |
Q76381436 | Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: A new risk factor for stroke? |
Q38014285 | Migraine and cardiovascular diseases |
Q38014284 | Migraine and sleep disorders |
Q69589798 | Migraine as a defect of brain oxidative metabolism: a hypothesis |
Q37470273 | Migraine as a visceral pain |
Q39297818 | Migraine. Treating acute migraine in the emergency department |
Q50755425 | Migraine: risk factor and comorbidity. |
Q44259611 | Mitochondrial DNA analysis in Leber's hereditary optic neuropathy |
Q34411109 | Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. |
Q57203457 | Mitochondrial complex III deficiency in a case of HCV related noninflammatory myopathy |
Q48276742 | Morvan chorea and agrypnia excitata: when video-polysomnographic recording guides the diagnosis |
Q41343900 | MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. |
Q48942547 | Multiple sclerosis-like disease in polyglandular autoimmune syndrome |
Q44901524 | Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? |
Q56980893 | Muscle and skin sympathetic activities in Ross syndrome |
Q28236796 | Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis |
Q40287142 | Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man. |
Q48432440 | Narcolepsy-like syndrome in multiple sclerosis |
Q48276734 | Narcoleptic-like hypersomnia and inverted circadian rhythm of body core temperature after traumatic brain injury involving the hypothalamus |
Q104692742 | Neuro-ophthalmological findings in early Fatal Familial Insomnia |
Q37592765 | Neuroethological approach to frontolimbic epileptic seizures and parasomnias: The same central pattern generators for the same behaviours. |
Q37982920 | Neuronal correlates to consciousness. The "Hall of Mirrors" metaphor describing consciousness as an epiphenomenon of multiple dynamic mosaics of cortical functional modules. |
Q38108480 | Nociception and autonomic nervous system |
Q48697135 | Nocturnal body core temperature falls in Parkinson's disease but not in Multiple-System Atrophy |
Q52648927 | Nocturnal melatonin regulation in post-traumatic vegetative state: a possible role for melatonin supplementation? |
Q70668704 | Non-invasive continuous cardiovascular monitoring in the vasodepressor form of carotid sinus hypersensitivity--confirmation of its value |
Q48293824 | Normal body scheme and absent phantom limb experience in amputees while dreaming |
Q48597733 | Normal sleep-wake and circadian rhythms in a case of Gerstmann-Sträussler-Sheinker (GSS) disease |
Q38052506 | Nuclear lamins: functions and clinical implications |
Q56978882 | Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophy |
Q40228807 | Oculomasticatory myorhythmia and agrypnia excitata guide the diagnosis of Whipple disease |
Q33860731 | Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers |
Q48266359 | Oneiric stupor: the peculiar behaviour of agrypnia excitata |
Q38173331 | Orexin/hypocretin system and autonomic control: new insights and clinical correlations |
Q38192976 | Orthostatic hypotension and cognitive impairment: a dangerous association? |
Q41570724 | Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD. |
Q42075104 | P027. Idiopathic intracranial hypertension without papilledema in refractory chronic daily headache |
Q36468553 | P037. Headache in multiple sclerosis: prevalence and clinical features in a case control-study |
Q43085669 | P044. Anger expression in chronic daily headache patients with and without psychiatric comorbidity |
Q38550835 | P063. Colloid cysts of the third ventricle: a case report |
Q34172948 | PARK6 is a common cause of familial parkinsonism |
Q48673610 | PARK6-linked parkinsonism occurs in several European families |
Q33157282 | Paroxysmal bipedal activity during syncope related to carotid body tumor |
Q33432509 | Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease |
Q56980152 | Peripheral autonomic neuropathy: diagnostic contribution of skin biopsy |
Q36750237 | Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center |
Q46519061 | Pharmacogenetics of headache treatment |
Q43827109 | Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families |
Q48198969 | Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease |
Q48258025 | Physiologic autonomic arousal heralds motor manifestations of seizures in nocturnal frontal lobe epilepsy: implications for pathophysiology |
Q37721252 | Physiological Mechanisms Mediating the Coupling between Heart Period and Arterial Pressure in Response to Postural Changes in Humans |
Q113319932 | Physiological responses to pain in cancer patients: A systematic review |
Q38765914 | Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease |
Q81462503 | Plasmapheresis improves the outcome of central pontine myelinolysis |
Q35936394 | Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study |
Q40957030 | Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients |
Q52732555 | Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in man. |
Q59690444 | Power Spectral Analysis of Heart Rate and Diastolic Blood Pressure Variability in Migraine with and Without Aura |
Q46884646 | Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. |
Q48100269 | Prevalence of fatigue in Parkinson disease and its clinical correlates |
Q84060121 | Primary and secondary Raynaud's phenomenon: does small neuropathy remain the same? |
Q90802929 | Progression and prognosis in multiple system atrophy presenting with REM behavior disorder |
Q48844465 | Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia |
Q72871471 | Propranolol in prophylaxis of migraine |
Q48545360 | Propriospinal myoclonus: a motor phenomenon found in restless legs syndrome different from periodic limb movements during sleep |
Q98164040 | Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome |
Q56993113 | Quality of life, eating and mood disorders in menstrual migraine: a case-control study |
Q57203482 | Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache |
Q37964079 | REM behaviour disorder and neurodegenerative diseases |
Q37830131 | Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy |
Q48811338 | Regional distribution of protease-resistant prion protein in fatal familial insomnia |
Q35973499 | Reply to Vera Osipova et al. |
Q90713808 | Reply to: Young- onset multiple system atrophy |
Q45209829 | Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy |
Q45209833 | Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations |
Q50639257 | Reversible postural tachycardia syndrome due to inadvertent overuse of Red Bull. |
Q102070094 | Risk of hospitalization and death for COVID-19 in people with Parkinson's disease or parkinsonism |
Q33409881 | Risk stratification of non-traumatic headache in the emergency department |
Q38662062 | Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording. |
Q56981850 | SPARTACUS: underdiagnosis of chronic daily headache in primary care |
Q30651646 | SUNCT/SUNA and neurovascular compression: new cases and critical literature review |
Q33505334 | Self-help group and medication overuse headache: preliminary data |
Q26751211 | Sensitization and Interoception as Key Neurological Concepts in Osteopathy and Other Manual Medicines |
Q38108479 | Sensitization and pain |
Q41233794 | Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study. |
Q56979083 | Skin sympathetic fiber α-synuclein deposits: a potential biomarker for pure autonomic failure |
Q46542986 | Sleep and temperature rhythms in two sisters with P102L Gerstmann-Sträussler-Scheinker (GSS) disease |
Q48030746 | Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study |
Q48374684 | Sleep--wake and body core temperature rhythms in multiple sclerosis with fatigue |
Q48443783 | Sleep-dependent changes in the coupling between heart period and blood pressure in human subjects |
Q48478924 | Sleep-related stridor due to dystonic vocal cord motion and neurogenic tachypnea/tachycardia in multiple system atrophy |
Q48820246 | Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. |
Q33534100 | Spectral analysis of heart rate variability reveals an enhanced sympathetic activity in narcolepsy with cataplexy. |
Q56362355 | Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges |
Q48440431 | Sporadic fatal insomnia in a fatal familial insomnia pedigree |
Q48915389 | Standing worsens cognitive functions in patients with neurogenic orthostatic hypotension |
Q93118713 | State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study |
Q48438051 | Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy |
Q90389489 | Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment |
Q45151495 | Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients |
Q48569340 | Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy. |
Q98663040 | Subcortical myoclonus in COVID-19: comprehensive evaluation of a patient |
Q33155945 | Sudden falls due to seizure-induced cardiac asystole in drug-resistant focal epilepsy |
Q50348906 | Superficial siderosis associated with peripheral autonomic failure and tetraventricular hydrocephalus: a case report |
Q48858295 | Switching on the deep brain stimulation: effects on cardiovascular regulation and respiration. |
Q80490208 | Sympathetic hyperactivity in patients with ulcerative colitis |
Q35211634 | Sympathetic skin response: basic mechanisms and clinical applications |
Q33157204 | Sympatho-vagal responses in patients with sleep and typical vasovagal syncope. |
Q57721345 | Testing Models for Genetic Determination in Migraine |
Q48243880 | Thalamic contribution to Sleep Slow Oscillation features in humans: a single case cross sectional EEG study in Fatal Familial Insomnia |
Q90703245 | The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population |
Q37643888 | The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice. |
Q38689674 | The association between restless legs syndrome, cardiovascular and metabolic diseases: hypotheses and evidence from the literature |
Q57005596 | The circadian rhythm of body core temperature (CRT) is normal in patient with congenital generalized anhidrosis |
Q40937082 | The concept of trophic units in the central nervous system |
Q48127788 | The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes |
Q30746238 | The expanding role of imaging in prion disease |
Q70261610 | The mesolimbic dopamine system: evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population |
Q37664035 | The primary headaches as a reflection of genetic darwinian adaptive behavioral responses |
Q35953463 | The role of cardiac diseases in the comorbidity between migraine and stroke. |
Q48939964 | The thalamus participates in the regulation of the sleep-waking cycle. A clinico-pathological study in fatal familial thalamic degeneration |
Q93561781 | The “typical” migraines: geneticstudies and some practical considerations |
Q33160773 | Tilt-induced cardioinhibitory syncope: a follow-up study in 16 patients. |
Q45031665 | Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: the infectious hypothesis revisited |
Q59389278 | Transdermal scopolamine cycloplegia in juvenile diabetes |
Q44489284 | Transient hypohidrosis induced by topiramate |
Q56968405 | Translation and linguistic validation of the Composite Autonomic Symptom Score COMPASS 31 |
Q92537234 | Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study |
Q48287826 | Traumatic intracystic hemorrhage in a case with thalamo-mesencephalic 'expanding lacunae': an uncommon cause of sudden-onset neurological signs |
Q42271737 | Treatment of withdrawal headache in patients with medication overuse headache: a pilot study |
Q55285207 | Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis. |
Q56989664 | Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres |
Q57767811 | Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension |
Q92677787 | Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study |
Q80347994 | Validation of AIDA Cefalee, a computer-assisted diagnosis database for the management of headache patients |
Q104276501 | Vessel-wall MRI in thunderclap headache: A useful tool to answer the riddle? |
Q30371685 | Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. |
Q38812246 | Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature |
Q48427810 | What are the causes of excessive daytime sleepiness in patients with sleep-disordered breathing? |
Q36475054 | Which therapy for which patient? |
Q48266487 | Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment |
Q57721322 | X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant |
Q56376833 | Young-onset multiple system atrophy: Clinical and pathological features |
Q57010549 | alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity |
Search more.